Cardiac Amyloidosis in 2023: Transformative Advances in Diagnosis and Therapy
Full Text:
Abstract
Cardiac amyloidosis, characterized by amyloid fibril deposition in the myocardium, has seen significant advancements in diagnosis and treatment over the past two decades. This paper reviews the current understanding of cardiac amyloidosis, emphasizing developments up to 2023, including novel diagnostic modalities, therapeutic strategies, and future research directions.JRCD 2023; 4(7): 145–150
key words:
Cardiac amyloidosis, amyloid fibril deposition, myocardium, diagnosis, treatment, advancements, 2023, diagnostic modalities, therapeutic strategies, future research directions
References
Wechalekar AD, Fontana M, Quarta CC, Liedtke M. AL amyloidosis for cardiologists: awareness, diagnosis, and future prospects: JACC: cardiooncology state-of-the-art review. Cardio Oncology. 2022 Nov 1;4(4):427-41.
Miller DV, Revelo MP. Diagnostic pathology: cardiovascular. Elsevier Health Sciences; 2023 Mar 7.
Yadav JD, Othee H, Chan KA, Man DC, Belliveau PP, Towle J. Transthyretin amyloid cardiomyopathy—current and future therapies. Annals of Pharmacotherapy. 2021 Dec;55(12):1502-14.
Castiglione V, Franzini M, Aimo A, Carecci A, Lombardi CM, Passino C, Rapezzi C, Emdin M, Vergaro G. Use of biomarkers to diagnose and manage cardiac amyloidosis. European Journal of Heart Failure. 2021 Feb;23(2):217-30.
Bajwa F, O’Connor R, Ananthasubramaniam K. Epidemiology and clinical manifestations of cardiac amyloidosis. Heart failure reviews. 2022 Sep;27(5):1471-84.
Cuddy SA, Bravo PE, Falk RH, El-Sady S, Kijewski MF, Park MA, Ruberg FL, Sanchorawala V, Landau H, Yee AJ, Bianchi G. Improved quantification of cardiac amyloid burden in systemic light chain amyloidosis: redefining early disease?. Cardiovascular Imaging. 2020 Jun 1;13(6):1325-36.
Banypersad SM, Moon JC, Whelan C, Hawkins PN, Wechalekar AD. Updates in cardiac amyloidosis: a review. Journal of the American Heart Association. 2012 Apr 23;1(2):e000364.
Rapezzi C, Aimo A, Serenelli M, Barison A, Vergaro G, Passino C, Panichella G, Sinagra G, Merlo M, Fontana M, Gillmore J. Critical comparison of documents from scientific societies on cardiac amyloidosis: JACC state-of-the-art review. Journal of the American College of Cardiology. 2022 Apr 5;79(13):1288-303.
Dorbala S, Cuddy S, Falk RH. How to image cardiac amyloidosis: a practical approach. Cardiovascular Imaging. 2020 Jun 1;13(6):1368-83.
Oda S, Kidoh M, Nagayama Y, Takashio S, Usuku H, Ueda M, Yamashita T, Ando Y, Tsujita K, Yamashita Y. Trends in diagnostic imaging of cardiac amyloidosis: emerging knowledge and concepts. Radiographics. 2020 Jul;40(4):961-81.
Patel KS, Hawkins PN. Cardiac amyloidosis: where are we today?. Journal of internal medicine. 2015 Aug;278(2):126-44.
Witteles RM, Liedtke M. AL amyloidosis for the cardiologist and oncologist: epidemiology, diagnosis, and management. Cardio Oncology. 2019 Sep 1;1(1):117-30.
Khor YM, Cuddy SA, Singh V, Falk RH, Di Carli MF, Dorbala S. 99mTc bone-avid tracer cardiac scintigraphy: role in noninvasive diagnosis of transthyretin cardiac amyloidosis. Radiology. 2022 Dec 20;306(2):e221082.
Bullock-Palmer RP. Diagnosing cardiac amyloidosis: a wealth of new possibilities with nuclear cardiac imaging. Journal of Nuclear Cardiology. 2021 Feb;28:219-24.
D’Aguanno V, Ralli M, Artico M, Russo FY, Scarpa A, Fiore M, Tirassa P, Severini C, de Vincentiis M, Greco A. Systemic amyloidosis: a contemporary overview. Clinical Reviews in Allergy & Immunology. 2020 Dec;59:304-22.
Ricci F, Ceriello L, Khanji MY, Dangas G, Bucciarelli-Ducci C, Di Mauro M, Fedorowski A, Zimarino M, Gallina S. Prognostic significance of cardiac amyloidosis in patients with aortic stenosis: a systematic review and meta-analysis. Cardiovascular Imaging. 2021 Jan 1;14(1):293-5.
Refbacks
- There are currently no refbacks.
